The Cancer Institute of New Jersey Hamilton — Hamilton, New Jersey

The Cancer Institute of New Jersey Hamilton is a clinical research site located in Hamilton, New Jersey, United States 08690.

Crixeo Health Trust Score: 84/100 (GOOD). This profile has not yet been claimed by the site owner.

The Cancer Institute of New Jersey Hamilton has participated in 58 clinical trials with 47 currently active.

Therapeutic areas: Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.

Sponsors: National Cancer Institute (NCI), ECOG-ACRIN Cancer Research Group, SWOG Cancer Research Network.

Sponsor Feasibility Report

Trust Score: 84/100. Verification status: Not yet accredited. Patient reviews: 0. Complaints: 0.

Frequently Asked Questions

What is the Trust Score for The Cancer Institute of New Jersey Hamilton?

The Cancer Institute of New Jersey Hamilton has a Crixeo Trust Score of 84/100 (GOOD). Trust Scores reflect trial volume, sponsor diversity, patient reviews, address verification, and accreditation status.

How many clinical trials has The Cancer Institute of New Jersey Hamilton conducted?

The Cancer Institute of New Jersey Hamilton has 58 clinical trials on record, with 47 currently active. Their work covers Metastatic Esophageal Adenocarcinoma, Metastatic Esophageal Squamous Cell Carcinoma, Metastatic Gastroesophageal Junction Adenocarcinoma.

Is The Cancer Institute of New Jersey Hamilton accredited by Crixeo Health?

The Cancer Institute of New Jersey Hamilton has not yet obtained Crixeo Accreditation. Site owners can claim their profile and apply for accreditation to improve visibility with sponsors and patients.

Can I submit a review or complaint about The Cancer Institute of New Jersey Hamilton?

Yes. Patients and trial participants can submit reviews and file complaints directly on this profile page. All submissions are reviewed before publication.